FILAO THERAPY: what changed
FILAO THERAPY
Largest movements
- Receivables within one year +€17,876
up €17,876 (+3,575%), from €500 to €18,376
- Cash -€7,370
down €7,370 (-80.5%), from €9,160 to €1,790
mainly Receivables within one year (-€17,876) and Investment in fixed assets (net) (-€900)
- Financial fixed assets +€900
new in 2024: €900
- Profit (loss) carried forward +€8,718
up €8,718 (+126%), from €6,908 to €15,626
- Tax, wage and social debts +€2,688
up €2,688 (+153%), from €1,752 to €4,440
- Gross operating margin +€2,954
up €2,954 (+34.1%), from €8,660 to €11,615
- Taxes +€936
up €936 (+53.4%), from €1,752 to €2,688
- Other operating charges +€184
new in 2024: €184
Change in the result, 2023 to 2024
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2023 and 2024 balance sheets and the 2024 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €9,660 | €21,066 | +€11,406 | +118% |
| Fixed assets | 21/28 | - | €900 | +€900 | |
| Financial fixed assets | 28 | - | €900 | +€900 | |
| Current assets | 29/58 | €9,660 | €20,166 | +€10,506 | +109% |
| Amounts receivable within one year | 40/41 | €500 | €18,376 | +€17,876 | +3,575% |
| Other amounts receivable | 41 | €500 | €18,376 | +€17,876 | +3,575% |
| Cash at bank and in hand | 54/58 | €9,160 | €1,790 | -€7,370 | -80.5% |
| Total equity and liabilities | 10/49 | €9,660 | €21,066 | +€11,406 | +118% |
| Equity | 10/15 | €7,908 | €16,626 | +€8,718 | +110% |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €6,908 | €15,626 | +€8,718 | +126% |
| Amounts payable | 17/49 | €1,752 | €4,440 | +€2,688 | +153% |
| Amounts payable within one year | 42/48 | €1,752 | €4,440 | +€2,688 | +153% |
| Taxes, remuneration and social security | 45 | €1,752 | €4,440 | +€2,688 | +153% |
| Taxes | 450/3 | €1,752 | €4,440 | +€2,688 | +153% |
| Other operating charges | 640/8 | - | €184 | +€184 | |
| Gross operating margin | 9900 | €8,660 | €11,615 | +€2,954 | +34.1% |
| Operating profit (loss) | 9901 | €8,660 | €11,431 | +€2,771 | +32.0% |
| Financial charges | 65/66B | - | €25 | +€25 | |
| Recurring financial charges | 65 | - | €25 | +€25 | |
| Profit (loss) for the period before taxes | 9903 | €8,660 | €11,406 | +€2,745 | +31.7% |
| Income taxes | 67/77 | €1,752 | €2,688 | +€936 | +53.4% |
| Profit (loss) for the period | 9904 | €6,908 | €8,718 | +€1,810 | +26.2% |
| Profit (loss) for the period to be appropriated | 9905 | €6,908 | €8,718 | +€1,810 | +26.2% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Green is a favourable move for that line, red an unfavourable one. Prepared on 8 November 2026 via checked.be.